A Phase III Study Comparing Cisplatin, Dacarbazine, Carmustine and Tamoxifen vs Dacarbazine Alone in Patients with Advanced Melanoma

Abstracts/Posters/Presentations:

• Saxman SB, Meyers ML, Chapman PB, Destro AN, Panageas KS, Begg CB, Monaco F, Agarwala SS, Schuchter LM, Ernstoff MS, Einhorn LH, Kirkwood JM,Houghton AN. A Phase III Multicenter Randomized Trial of DTIC, Cisplatin, BCNU and Tamoxifen Versus DTIC Alone in Patients with Metastatic Melanoma: A Hoosier Oncology Group and Walther Cancer Institute trial MEL91-1, Indianapolis, IN. Accepted to the ASCO annual meeting May 15-18, 1999, Atlanta, GA